This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

GlucAffect Blood Sugar Management Formula From Reliv Earns Patent

Stocks in this article: RELV

CHESTERFIELD, Mo., Feb. 21, 2012 /PRNewswire/ -- Reliv International announced that GlucAffect®, Reliv's blood sugar management supplement, has earned a patent from the US government. Dr. Carl W. Hastings, Reliv's chief scientific officer and creator of GlucAffect, made the announcement as part of opening night at Reliv's 2012 National Conference.

"Earning this patent validates the work our R&D team put into making GlucAffect a superior nutritional approach to blood sugar management," Hastings said. "GlucAffect addresses one of today's biggest health problems — metabolic syndrome — like no other product available. Most importantly, it works."

View GlucAffect clinical trial

In an eight-week, placebo-controlled clinical study of 50 overweight individuals with elevated blood glucose levels, test subjects taking GlucAffect lowered their fasting blood glucose by an average of 30%, moving from elevated glucose levels to healthy blood sugar values. In addition, those individuals taking GlucAffect lost an average of nearly 16 pounds during the eight-week period. No significant glucose lowering or weight loss was found in the control group.

Elevated blood glucose levels and being overweight are key factors in metabolic syndrome, which dramatically increases the likelihood of developing diseases such as diabetes, heart disease and stroke. According to the American Heart Association, metabolic syndrome affects about 35 percent of American adults.

"Metabolic syndrome is a serious, emerging health concern among the medical community, and physicians are more frequently looking to nutrition science to complement traditional care and prescriptive remedies," Dr. Hastings said. "We see the GlucAffect study results and the success stories of GlucAffect consumers as validation of nutrition's important role."

Learn more about GlucAffect

One of GlucAffect's main active ingredients, Pycnogenol®, is an antioxidant clinically shown to help lower high blood glucose levels and provide other health benefits. Additional key ingredients in GlucAffect include omega-3 fish oils, Madeglucyl™, Glucohelp®, Silbinol ® and cinnamon, among others.

GlucAffect becomes the sixth patented Reliv nutritional formula, joining Arthaffect® for joint health, Cellebrate® for weight loss, FibRestore® for digestive health, Innergize!® for performance nutrition and ReversAge® for anti-aging nutrition.

1 of 2

Select the service that is right for you!

Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,778.15 +421.28 2.43%
S&P 500 2,061.23 +48.34 2.40%
NASDAQ 4,748.3960 +104.0840 2.24%

Brokerage Partners

Rates from

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs